Skin cancer is the most common malignancy in fair-skinned populations, with melanoma incidence the highest in New Zealand and Australia (50 and 48 per 100 000 population, respectively) and projected to increase in the UK (from 17 to 36 per 100 000 population) and in the USA (from 29 to 32 per 100 000 population) between 2007–11 and 2022–26.1 Non-melanoma skin cancer is up to 20 times more common than melanoma worldwide.2 For every melanoma diagnosed, there are from three to 40 benign lesions biopsied; the proportion of biopsied lesions that are benign is generally greater in primary care than in specialist settings.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qyLkwD
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Many different quantitative techniques have been developed to either assess Environmental Justice (EJ) issues or estimate exposure and dose ...
-
Leddsmerter kan ha mange årsaker. Traumatiske, immunologiske og infeksiøse lidelser må vurderes. En god anamnese kan sette oss på rett spor...
-
Trends in Otolaryngology Consultation Patterns at an Academic Quaternary Care Center. JAMA Otolaryngol Head Neck Surg. 2017 Jan 05;: ...
-
Abstract An intriguing piece of evidence for the inflammatory story of type 2 diabetes has come to the light. A recent study by Okin and co...
-
Variable Speed Limit Sign (VSLS) Systems enable speed limits to be changed dynamically in response to traffic conditions so that traffic inc...
-
Outcomes of Drug-Induced Sleep Endoscopy-Directed Surgery for Pediatric Obstructive Sleep Apnea. Otolaryngol Head Neck Surg. 2017 Nov ...
-
The promise of omics-based approaches to cancer prevention. Semin Oncol. 2016 Feb;43(1):36-48 Authors: Meerzaman D, Dunn BK, Lee M, C...
-
Prof Stupp speaks with ecancer at AACR 2017 about developing treatments for glioblastoma, from temozolomide and chemotherapy to novel tumour...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου